Jane Street’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Jane Street's ASND Position: Q3 2026 in Review
Jane Street sold out of Ascendis Pharma (ASND) in Q3 2026, closing a stake of 187,141 shares — an estimated $47.4M sold.
Jane Street first reported a position in ASND in Q3 2017 and held it in 24 quarters. The position peaked at $49.9M in Q2 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Jane Street reported no remaining Ascendis Pharma position as of Q3 2026 after selling out during the quarter.
- Jane Street sold 187,141 Ascendis Pharma shares in Q3 2026, an estimated $47.4M.
- Jane Street first reported a position in Ascendis Pharma in Q3 2017 and held it in 24 quarters.
- Jane Street's Ascendis Pharma position peaked at $49.9M in Q2 2026.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.